Cargando…

Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry

Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Borjas Howard, Jaime, Ruiz‐Sada, Pablo, de Leeuw, Karina, López‐Jiménez, Luciano, Font, Carme, Marchena, Pablo Javier, Madridano, Olga, Debourdeau, Philippe, Meijer, Karina, Monreal, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362114/
https://www.ncbi.nlm.nih.gov/pubmed/34075574
http://dx.doi.org/10.1111/bjh.17549
_version_ 1783738092007456768
author Borjas Howard, Jaime
Ruiz‐Sada, Pablo
de Leeuw, Karina
López‐Jiménez, Luciano
Font, Carme
Marchena, Pablo Javier
Madridano, Olga
Debourdeau, Philippe
Meijer, Karina
Monreal, Manuel
author_facet Borjas Howard, Jaime
Ruiz‐Sada, Pablo
de Leeuw, Karina
López‐Jiménez, Luciano
Font, Carme
Marchena, Pablo Javier
Madridano, Olga
Debourdeau, Philippe
Meijer, Karina
Monreal, Manuel
author_sort Borjas Howard, Jaime
collection PubMed
description Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03‐1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks.
format Online
Article
Text
id pubmed-8362114
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83621142021-08-17 Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry Borjas Howard, Jaime Ruiz‐Sada, Pablo de Leeuw, Karina López‐Jiménez, Luciano Font, Carme Marchena, Pablo Javier Madridano, Olga Debourdeau, Philippe Meijer, Karina Monreal, Manuel Br J Haematol Platelets, Haemostasis and Thrombosis Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03‐1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks. John Wiley and Sons Inc. 2021-06-02 2021-07 /pmc/articles/PMC8362114/ /pubmed/34075574 http://dx.doi.org/10.1111/bjh.17549 Text en © 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Platelets, Haemostasis and Thrombosis
Borjas Howard, Jaime
Ruiz‐Sada, Pablo
de Leeuw, Karina
López‐Jiménez, Luciano
Font, Carme
Marchena, Pablo Javier
Madridano, Olga
Debourdeau, Philippe
Meijer, Karina
Monreal, Manuel
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
title Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
title_full Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
title_fullStr Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
title_full_unstemmed Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
title_short Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
title_sort risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the registro informatizado de enfermedad tromboembólica (riete) registry
topic Platelets, Haemostasis and Thrombosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362114/
https://www.ncbi.nlm.nih.gov/pubmed/34075574
http://dx.doi.org/10.1111/bjh.17549
work_keys_str_mv AT borjashowardjaime riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT ruizsadapablo riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT deleeuwkarina riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT lopezjimenezluciano riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT fontcarme riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT marchenapablojavier riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT madridanoolga riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT debourdeauphilippe riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT meijerkarina riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT monrealmanuel riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry
AT riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry